Episode 20 – Eric Topol & Dennis Burton: Antibodies, Vaccines and the Current State of COVID-19

Science Changing Life

Today’s special edition features an extended conversation between Dr. Eric Topol, Director of the Scripps Research Translational Institute, and Professor Dennis Burton, Chair of the Department of Immunology and Microbiology at Scripps Research. Listen as they talk about antibody cocktail treatments, the mystery of “longhaul” COVID-19 symptoms and how close we are to developing a coronavirus vaccine. Transcript of today's episode https://www.scripps.edu/covid-19/videos/topol-burton/index.html Dr. Eric Topol’s bio https://www.scripps.edu/faculty/topol/ Prof. Dennis Burton’s bio https://www.scripps.edu/faculty/burton/ Efficacy of convalescent plasma https://www.sandiegouniontribune.com/business/biotech/story/2020-08-30/hundreds-of-san-diegans-with-covid-19-have-already-been-treated-with-plasma-but-does-it-work “COVID longhaulers” https://www.theatlantic.com/health/archive/2020/08/long-haulers-covid-19-recognition-support-groups-symptoms/615382/ Coronavirus vaccine Q&A with Prof. Dennis Burton https://www.sandiegouniontribune.com/business/biotech/story/2020-07-26/q-a-an-update-on-the-race-for-a-covid-19-vaccine-scripps-research-immunologist-dennis-burton Dr. Eric Topol on social media: Twitter: @EricTopol Instagram: @erictopol1 Scripps Research on social media: Twitter, Instagram: @scrippsresearch Facebook: @ScrippsResearchInstitute LinkedIn: the-scripps-research-institute